CCL downgraded its outlook for 1H17 due to weakness in the Australian beverage performance.
CCL expects underlying NPAT will decline in 1H17 and expects FY17 NPAT to be in line with FY16 at around $420m
You're not a member! Trial today
If we assume no earnings growth into FY18 and a continuation of the $0.45 cent per year dividend, it places the stock on a forward yield of 4.6%.
FY18 revenue $5.2b, EBIT $680m & EPS $0.54.
